Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000908834-22-000028
Filing Date
2022-02-03
Accepted
2022-02-03 09:22:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT #1 13g1_imago.htm SC 13G/A 368551
  Complete submission text file 0000908834-22-000028.txt   370180
Mailing Address ONE MARITIME PLAZA SUITE 2100 SAN FRANCISCO CA 94111
Business Address ONE MARITIME PLAZA SUITE 2100 SAN FRANCISCO CA 94111 (415)421-2132
FARALLON CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000909661 (see all company filings)

EIN.: 943240279 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 650 325 5156
Imago BioSciences, Inc. (Subject) CIK: 0001623715 (see all company filings)

EIN.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92697 | Film No.: 22586778
SIC: 2834 Pharmaceutical Preparations